Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis Patients
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if sevelamer carbonate powder is an effective
treatment for the control of serum phosphorous levels in patients on dialysis when compared
to sevelamer hydrochloride tablets.